Russia doesn't understand why Kiev still continues operation in Donbass — LavrovRussian Politics & Diplomacy December 02, 22:59
Russian field engineers take off for Syria to take part in Aleppo demining operationMilitary & Defense December 02, 21:24
Putin praises Hermitage Museum for its efforts in restoring PalmyraSociety & Culture December 02, 21:03
Lavrov says 'Crimea is not a problem, it is a part of Russia'Russian Politics & Diplomacy December 02, 20:42
Russian top diplomat says Syria cannot repeat Libya’s fateRussian Politics & Diplomacy December 02, 19:53
Key facts about the '90s price liberalization in RussiaBusiness & Economy December 02, 19:46
Russia's antimonopoly watchdog: Google will not 'get off with fines'Business & Economy December 02, 19:32
Lavrov wonders why UN is not using Castello Road to deliver humanitarian aid to AleppoRussian Politics & Diplomacy December 02, 19:24
Top diplomat calls to motivate Libyan parties towards mutually acceptable agreementsRussian Politics & Diplomacy December 02, 19:02
MOSCOW, December 22. /TASS/. Some 16 major Russian pharmaceutical companies have stopped the production of “the cheapest and the most essential drugs,” including antibiotics and fluids, the chairman of the State Duma health committee Sergey Kalashnikov said on Monday.
“This comes due to a sharp increase in the dollar price for the substances which are bought abroad,” Kalashnikov said, adding that the prime cost of medicines is now some three or four times higher than the actual price amid weakened ruble.
The members of the State Duma health committee as well as representatives of the Russian Health Ministry, the Ministry of Industry and Trade, the Federal Anti-Monopoly Service and the Federal Tariff Service are due to focus on the situation at an urgent meeting later on Monday.
“The main goal is to develop a concept for work in emergency conditions to ensure uninterrupted access to medicines,” Kalashnikov said, explaining that the idea is to adjust prices for foreign-made life-saving drugs and resume the production of pharmaceutical substances in Russia.
The lawmaker in particular proposes that Russia should follow the example of India and Brazil and introduce a mechanism of mandatory licensing when “it is allowed to manufacture medicines, generics if a patent has not expired.” This concerns the “most expensive medicines” which are used to treat such diseases as cancer and AIDS, he said.